| Schedule of Basic and Diluted Income (Loss) Per Share |
The following table presents the calculation of basic and diluted loss per share: | | | | | | | | | | | | | | | | | | | | | | | | | (in millions, except share and per share data) | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2021 | | 2022 | | 2021 | | 2022 | | Net loss | $ | (1,317) | | | $ | (175) | | | $ | (3,264) | | | $ | (862) | | | Less: allocation of earnings to participating securities | — | | | — | | | — | | | — | | | Net loss attributable to common stockholders | $ | (1,317) | | | $ | (175) | | | $ | (3,264) | | | $ | (862) | | | | | | | | | | | Weighted-average common shares outstanding - basic | 638,168,188 | | | 882,356,575 | | | 368,518,894 | | | 875,055,571 | | | Dilutive effect of stock options and unvested shares | — | | | — | | | — | | | — | | | Weighted-average common shares used to compute diluted loss per share | 638,168,188 | | | 882,356,575 | | | 368,518,894 | | | 875,055,571 | | | | | | | | | | | Net loss per share attributable to common stockholders: | | | | | | | | | Basic | $ | (2.06) | | | $ | (0.20) | | | $ | (8.85) | | | $ | (0.99) | | | Diluted | $ | (2.06) | | | $ | (0.20) | | | $ | (8.85) | | | $ | (0.99) | |
|
| Schedule of Potential Common Shares Excluded from the Calculation of Diluted Net Income (Loss) Per Share |
The following potential common shares were excluded from the calculation of diluted net loss per share because their effect would have been anti-dilutive or issuance of such shares is contingent upon the satisfaction of certain conditions which were not satisfied by the end of the period: | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended
September 30, | | Nine Months Ended
September 30, | | 2021 | | 2022 | | 2021 | | 2022 | | | | | | | | | | RSUs | 112,492,359 | | | 130,510,263 | | | 112,492,359 | | | 130,510,263 | | | Stock options | 15,447,206 | | | 15,905,575 | | | 15,447,206 | | | 15,905,575 | | | Early-exercised stock options | 65,435 | | | — | | | 65,435 | | | — | | | Warrants | 14,278,034 | | | 14,278,034 | | | 14,278,034 | | | 14,278,034 | | | ESPP shares | 93,738 | | | 824,292 | | | 93,738 | | | 824,292 | | | Total anti-dilutive securities | 142,376,772 | | | 161,518,164 | | | 142,376,772 | | | 161,518,164 | |
|